Akira Endo
Drug Fostering and Evolution Coordination Department, Eisai Co., Ltd.
2
0
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Hiroki Shimizu
Eisai Co., Ltd.
Shared therapeutic areas:
Worked with same sponsors:
Subsai Kongsaengdao
Division of Neurology, Department of Medicine, Rajavithi Hospital, Department of Medical services, Public Health Ministry, Bangkok, 10400 Thailand 3 Department of Medicine, College of Medicine, Rangsit University, Bangkok, 10400 Thailand
Shared therapeutic areas:
Robert Chen, MD
University Health Network, Toronto
Shared therapeutic areas:
Sehim Sehim
sehim.kutlay@gmail.com
Shared therapeutic areas:
Michael Kulagowski, MD
Merz North America, Inc.
Shared therapeutic areas:
Vincenzo Di Lazzaro, MD
Campus Bio-Medico Hospital
Shared therapeutic areas:
Zelma Kiss, MD
University of Calgary
Shared therapeutic areas:
Carolyn Austin
Mentor Worldwide, LLC
Shared therapeutic areas:
Michael S Okun, MD
University of Florida
Shared therapeutic areas:
Lauren Fanty, MD
University of Florida
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A
Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia
All 2 trials loaded